SCOPE 2

Trial SCOPE 2
Cancer Type Oesophageal Cancer
Hospital(s) Belfast City Hospital
Information

A randomised Phase II/III trial to study radiotherapy dose escalation in patients with
oesophageal cancer treated with definitive chemo-radiation with an embedded Phase II trial for patients
with a poor early response using positron emission tomography (PET)
Click Here to view CancerHelpUK trial summary
Posted in .